IDH1 and glioblastoma: In our cohort, all LGGs (n = 19) and six out of 53 (11.3%) of the glioblastomas harbored IDH1 mutations; among the LGGs, nine (47.4%) showed 1p19q co-deletion, while no samples showed 1p19q co-deletion in glioblastomas.